News | Enterprise Imaging | February 18, 2021

Intelerad Acquires Healthcare Analytics Vendor Lumedx

Acquisition marks Intelerad’s third in six months, expanding ability to provide enterprise imaging and insights and deepening its cardiovascular expertise

 Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired Lumedx, a leading provider of healthcare analytics and cardiovascular information systems (CVIS). 

February 18, 2021 – Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired Lumedx, a leading provider of healthcare analytics and cardiovascular information systems (CVIS)

On the heels of its recent acquisition of Digisonics Inc., which bolstered the company’s portfolio of solutions for cardiovascular and obstetrics/gynecology. The Lumedx acquisition expands the breadth and reach of Intelerad’s offerings through an expanded suite of solutions, further positioning the company as a leader in the cardiovascular space. 

“Healthcare as we know it has forever changed, and more than ever, providers need automated solutions that allow them to focus on what they do best – treating patients and providing improved patient care,” said Mike Lipps, CEO of Intelerad. “Bringing Lumedx into the Intelerad portfolio further enables our team to provide customers with the most comprehensive enterprise imaging platform in the industry.” 

As a result of the COVID-19 pandemic, cardiovascular procedures declined significantly as elective and other procedures were put on hold. However, this is expected to dramatically rebound in 2021. Delivering a comprehensive enterprise imaging platform — including robust cardiovascular offerings — is critical as hospitals, health systems and imaging centers seek to consolidate their enterprise imaging requirements on a single-vendor platform, further driving clinical efficiency and patient care. 

For more than 25 years, Lumedx helped improve the continuity of care through its cardiovascular data intelligence, cardiovascular information systems (CVIS) and cardiac PACS (CPACS). It also provides analytics for multiple specialties, including orthopedics, neurology, spine and maternal/fetal medicine. The company currently serves more than 650 hospitals and health systems, with proven success in helping customers achieve better patient care. 

The company offers cardiology specific solutions for structured reporting, ECG management, inventory, billing, scheduling. It also is a top provider of American College of Cardiology (ACC) NCDR and Society of Thoracic Surgeons (STS) registry software.

“Over the last two and a half decades, Lumedx has been laser-focused on our vision of delivering an end-to-end suite of software and services that improves continuity of care,” said Allyn McAuley, Ph.D., chief executive officer and co-founder of Lumedx. “Joining forces with Intelerad enables us to further achieve this goal, as well as provide customers increased automation that results in greater clinical efficiency and improved patient care.”

In 2020, Intelerad also acquired Radius, a private cloud platform provider, and was awarded Best in KLAS Recognition for PACS Asia/Oceania in the 2020 Best in KLAS Global Report

The Lumedx acquisition marks Intelerad’s third deal in just six months, extending a period of rapid growth for the company. Financial terms of the acquisition will not be disclosed. 

“Since its beginning, Intelerad has played a critical role in building and delivering technology that helps radiologists work more efficiently and maximize the value they add,” said Jean-Baptiste Brian, Intelerad board member and Partner at Hg, which owns Intellerad. “The addition of Lumedx will further enhance Intelerad’s product offerings while enabling the organization to provide new technologies and capabilities.”

Hg is a leading European investor in software and services, focused on backing businesses that change how we all do business. Hg has funds under management of over $30 billion, with an investment team of over 120 professionals, plus a portfolio team of more than 30 operators, providing practical support to help its businesses to realize growth ambitions. Based in London, Munich and New York, Hg has a portfolio of over 30 software and technology businesses, comprising over 35,000 employees across the U.K., U.S. and Europe. 

For more information: www.intelerad.com/en, www.lumedx.com

 

Related Intelerad and Lumedx Content:

Intelerad Acquires Digisonics to Expand its Enterprise Imaging Workflow 

Lumedx to Demonstrate Value of Advanced Analytics at HIMSS

Consolidation of Cardiology Data and its Integration Into the EMR

Lumedx Showcases Cardiovascular Imaging at RSNA

VIDEO: Lumedx Cardiovascular Performance Program: A New Approach to Managing Quality and Cost

 

Lumedx, DASpecialists Partner to Enhance Cardiovascular Registries Data Collection

Structured Reporting Has Become Key in New CVIS System Adoption

Trends in ECG Management Systems

What to Look for In Echo Reporting Software Systems

What to Look for in a Cardiology Inventory Tracking System

 

Adventist Health System Selects Lumedx Data Intelligence Solutions to Enhance Cardiovascular Care

Advanced Analytics Software for Cardiology

Baylor Scott & White Implements Lumedx Data Solutions

Related Content

Axial FLAIR MR image shows T2 prolongation in bilateral middle cerebellar peduncles (arrows). Findings were associated with restricted diffusion and areas of T1 hypointense signal without enhancement or abnormal susceptibility. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

Axial FLAIR MR image shows T2 prolongation in bilateral middle cerebellar peduncles (arrows). Findings were associated with restricted diffusion and areas of T1 hypointense signal without enhancement or abnormal susceptibility. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | February 22, 2021
February 22, 2021 — According to an...
Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in

Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen radiography (a,d) and benchmarked against histopathology (c,f). he top row focuses on the similarity between the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All this is confirmed by the histological slice in (c), and hardly visible in the conventional image in (a). The bottom row focuses on the detection of small calcifications, a key feature in DCIS. These are undetectable in (d), detected in (e), enhanced in the maximum intensity projection (MIP) image at the bottom of (f), and confirmed by histopathology in the top part of (f). The scale bar [shown in (b) and (e)] is the same for all images apart from (f), which has its own scale. Red arrows in (e) and (f) indicate the microcalcifications. Image courtesy of Professor Alessandro Olivo

News | Breast Imaging | February 22, 2021
February 22, 2021 — A new X-ray imaging scanne
Dr Sahar Saleem placing the mummy in the CT scanner

Dr. Sahar Saleem placing the mummy in the CT scanner. Image courtesy of Sahar Saleem

News | Computed Tomography (CT) | February 22, 2021
February 22, 2021 — Modern medical technology is helping scholars tell a more nuanced story about the fate of an anci
Example MR images from paediatric brain tumour patients. This first column shows T1-weighted images following the injection of gadolinium contrast agent. The second column shows T2-weighted images and the final column shows apparent diffusion coefficient maps calculated from diffusion-weighted images. (a–c) are taken from a patient with a Pilocytic Astrocytoma, (d–f) are from a patient with an Ependymoma and (g–i) were acquired from a patient with a Medulloblastoma.

Example MR images from paediatric brain tumour patients. This first column shows T1-weighted images following the injection of gadolinium contrast agent. The second column shows T2-weighted images and the final column shows apparent diffusion coefficient maps calculated from diffusion-weighted images. (ac) are taken from a patient with a Pilocytic Astrocytoma, (df) are from a patient with an Ependymoma and (gi) were acquired from a patient with a Medulloblastoma. Image courtesy of Nature Research Journal

News | Pediatric Imaging | February 17, 2021
February 17, 2021 — Diffusio...
T1 structural images for the two sequences, MPRAGE and MPRAGE+PMC. The top row shows the MPRAGE sequence, while the bottom row shows the images that were generated with the MPRAGE+PMC sequence. Columns represent two different participants, one with minimal head motion (left, Low-Mover) and another with a large quantity of motion (right, High-Mover). Pial and white matter (WM) surface reconstruction from Freesurfer are also shown.

T1 structural images for the two sequences, MPRAGE and MPRAGE+PMC. The top row shows the MPRAGE sequence, while the bottom row shows the images that were generated with the MPRAGE+PMC sequence. Columns represent two different participants, one with minimal head motion (left, Low-Mover) and another with a large quantity of motion (right, High-Mover). Pial and white matter (WM) surface reconstruction from Freesurfer are also shown.

News | Magnetic Resonance Imaging (MRI) | February 17, 2021
February 17, 2021 — A new paper,...
Radiology, radiation therapy, PACS, Enterprise image, X-ray, DR Systems, CT, MRI, contrast, ultrasound, VNA, product comparisons, comparison charts on ITN magazine.
Feature | February 17, 2021
Imaging Technology News (ITN) maintains more than 40
Insightec plans to expand in Latin America through a partnership with Strattner
News | Focused Ultrasound Therapy | February 16, 2021
February 16, 2021 — Insightec, a global healthcare company focused on creating the next generation of patient care, a
The British Institute of Radiology supports the proposal by AXREM that staff members from private suppliers who work shoulder to shoulder with National Health Service (NHS) staff in high-risk areas in hospitals should be recognised as frontline health and social care staff and prioritised for COVID-19 vaccination accordingly.

Getty Images

News | Coronavirus (COVID-19) | February 12, 2021
February 12, 2021 — The British Institute of Radiology supports the proposal by...